Cancer nanomedicines: closing the translational gap

Lancet. 2014 Dec 20;384(9961):2175-6. doi: 10.1016/S0140-6736(14)61457-4. Epub 2014 Dec 19.

¹ Shaare Zedek Medical Center and Hebrew University-School of Medicine, Jerusalem, Israel.
² Sloan Kettering Institute for Cancer Research and Weill Medical College of Cornell University, New York, NY, USA.
³ Alliance for Nanotechnology in Cancer, National Cancer Institute, Bethesda, MD 20892, USA.
⁴ UNC Eshelman School of Pharmacy, UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
⁵ Albert Einstein College of Medicine, New York, NY, USA.
⁶ Alliance for Nanotechnology in Cancer, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: [email protected].

No abstract available

MeSH terms